dihexa risks Capsules 10mg for Research Dihexa UK: Evidence-Based Peptide Research

Suspected adverse reactions to any medicine, including unlicensed products, should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk

In general, intravenous infusions or injections are not prohibited if they are legitimately received in the course of a hospital treatment, surgical procedure or clinical investigation or if they do not exceed 100 mL per 12 hour period

Every patient at our Reston clinic receives a personalized evaluation

Sterilize the Stopper: Before every single puncture, vigorously scrub the surface of the rubber stopper with a sterile 70% isopropyl alcohol prep pad

doi: 10.3390/ijms20040904